Literature DB >> 2449807

Recruitment of ineffective synapses after injury.

P D Wall1.   

Abstract

This paper describes three ways in which cells may expand their receptive fields with no concurrent change of morphology. (a) The subliminal fringe. Classical physiology described the presence of excitatory inputs that were not sufficiently strong to raise the cells above its firing threshold unless there was a decrease of inhibition or a summation of excitatory inputs. (b) Receptive-field expansion triggered by the arrival of impulses but sustained by central mechanisms. (c) Receptive-field expansion following a change in the transport of substances into the region of synapses.

Mesh:

Year:  1988        PMID: 2449807

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  5 in total

1.  Interlimb reflexes following cervical spinal cord injury in man.

Authors:  B Calancie
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 2.  AMPA-silent synapses in brain development and pathology.

Authors:  Eric Hanse; Henrik Seth; Ilse Riebe
Journal:  Nat Rev Neurosci       Date:  2013-11-08       Impact factor: 34.870

3.  Prevention and reversal of latent sensitization of dorsal horn neurons by glial blockers in a model of low back pain in male rats.

Authors:  Juanjuan Zhang; Siegfried Mense; Rolf-Detlef Treede; Ulrich Hoheisel
Journal:  J Neurophysiol       Date:  2017-06-14       Impact factor: 2.714

4.  Short-term afferent axotomy increases both strength and depression at Ia-motoneuron synapses in Rat.

Authors:  K L Seburn; T C Cope
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

5.  Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord.

Authors:  Lisa Schnell; Arsen S Hunanyan; William J Bowers; Philip J Horner; Howard J Federoff; Miriam Gullo; Martin E Schwab; Lorne M Mendell; Victor L Arvanian
Journal:  Eur J Neurosci       Date:  2011-10-13       Impact factor: 3.386

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.